Coevolution and HBV drug resistance.

Abstract excerpt

A high rate of mutation sets a strong foundation for the development of resistance to antiviral drugs. However, the ubiquitous presence of drug resistance mutations in the HBV population does not explain variations in the rate and specific types of drug resistance among patients. These variations can be explained by consideration of coevolution among individual sites in the HBV genome, viral variants and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hepatitis B virus
• Share to Antiviral Agents
• Share to Drug Resistance, Viral